Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The effects of quality of care on costs: a conceptual framework.

Nuckols TK, Escarce JJ, Asch SM.

Milbank Q. 2013 Jun;91(2):316-53. doi: 10.1111/milq.12015. Review.

2.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
3.

Invasive home mechanical ventilation, mainly focused on neuromuscular disorders.

Geiseler J, Karg O, Börger S, Becker K, Zimolong A.

GMS Health Technol Assess. 2010 Jun 14;6:Doc08. doi: 10.3205/hta000086.

4.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644
5.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

6.

Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Korczak D, Dietl M, Steinhauser G.

GMS Health Technol Assess. 2011 Apr 1;7:Doc02. doi: 10.3205/hta000093.

7.

Methods for the comparative evaluation of pharmaceuticals.

Zentner A, Velasco-Garrido M, Busse R.

GMS Health Technol Assess. 2005 Nov 15;1:Doc09.

8.

Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis.

Giorda CB, Nicolucci A, Pellegrini F, Kristiansen CK, Hunt B, Valentine WJ, Vespasiani G.

Diabet Med. 2014 May;31(5):615-23. doi: 10.1111/dme.12366. Epub 2013 Dec 24.

PMID:
24246087
9.

An overview of methods and applications to value informal care in economic evaluations of healthcare.

Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB.

Pharmacoeconomics. 2008;26(4):269-80.

PMID:
18370563
10.
11.

Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.

Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S, Nicholl JP.

Health Technol Assess. 2005 Aug;9(32):iii-iv, ix-x, 1-109.

12.

Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.

Cheng JS, Tsai WC, Lin CL, Chen L, Lang HC, Hsieh HM, Shin SJ, Chen T, Huang CT, Hsu CC.

Med Care. 2015 Feb;53(2):116-24. doi: 10.1097/MLR.0000000000000288.

PMID:
25517075
14.

The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.

Hoerger TJ, Ahmann AJ.

J Manag Care Pharm. 2008 Feb;14(1 Suppl C):S2-14; quiz 15-6. Review.

PMID:
18240890
15.

The effect of financial incentives on the quality of health care provided by primary care physicians.

Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008451. doi: 10.1002/14651858.CD008451.pub2. Review.

PMID:
21901722
16.

A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial.

Whitehurst DG, Lewis M, Yao GL, Bryan S, Raftery JP, Mullis R, Hay EM.

Arthritis Rheum. 2007 Apr 15;57(3):466-73.

17.

Health care resource use associated with integrated psychological treatment.

Vasiliadis HM, Briand C, Lesage A, Reinharz D, Stip E, Nicole L, Lalonde P.

J Ment Health Policy Econ. 2006 Dec;9(4):201-7.

PMID:
17200597
18.

Mobile phone messaging for preventive health care.

Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007457. doi: 10.1002/14651858.CD007457.pub2. Review.

PMID:
23235643
19.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
20.

The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.

McGuire H, Kissimova-Skarbek K, Whiting D, Ji L.

Diabetes Res Clin Pract. 2011 Nov;94(2):307-10. doi: 10.1016/j.diabres.2011.10.016. Epub 2011 Nov 5.

PMID:
22056720

Supplemental Content

Support Center